Effects of acute olanzapine after sustained fluoxetine on extracellular monoamine levels in the rat medial prefrontal cortex

被引:25
|
作者
Amargós-Bosch, M [1 ]
Artigas, F [1 ]
Adell, A [1 ]
机构
[1] CSIC, Inst Invest Biomed Barcelona, Dept Neurochem, IDIBAPS, E-08036 Barcelona, Spain
关键词
medial prefrontal cortex; fluoxetine; olanzapine; microdialysis; osmotic minipump;
D O I
10.1016/j.ejphar.2005.05.004
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The combination of selective serotonin reuptake inhibitors with atypical antipsychotic drugs exhibits beneficial effects in treatment-resistant depression. We investigated the effects of a 2-week treatment with a low fluoxetine dose (3 mg/kg per day) plus a single injection of olanzapine (3 mg/kg) on the dialysate concentration of noradrenaline, dopamine and serotonin (5-HT) in the medial prefrontal cortex of the rat. Chronic fluoxetine increased only 5-HT levels whereas single olanzapine administration increased the concentration of catecholamines and decreased that of 5-HT to a comparable extent in vehicle- and fluoxetine-treated rats. Therefore, it is possible that the therapeutic benefit of this pharmacological combination may not be associated to changes in the cortical concentration of monoamines, but to postsynaptic blockade of monoaminergic receptors. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:235 / 238
页数:4
相关论文
共 50 条
  • [1] Electrophysiological effects of acute and chronic olanzapine and fluoxetine in the rat prefrontal cortex
    Rasmussen, K
    Gronier, B
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S217 - S218
  • [2] Electrophysiological effects of acute and chronic olanzapine and fluoxetine in the rat prefrontal cortex
    Gronier, BS
    Rasmussen, K
    [J]. NEUROSCIENCE LETTERS, 2003, 349 (03) : 196 - 200
  • [3] Synergistic effects of the olanzapine and fluoxetine combination (OFC) on norepinephrine and dopamine extracellular levels in rat prefrontal cortex
    Bymaster, FP
    Nakazawa, T
    Yamaguchi, T
    Nomikos, G
    Koch, S
    Perry, KW
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2002, 17 : S128 - S128
  • [4] Effect of amphetamine on extracellular acetylcholine and monoamine levels in subterritories of the rat medial prefrontal cortex
    Hedou, G
    Homberg, J
    Martin, S
    Wirth, K
    Feldon, J
    Heidbreder, CA
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 390 (1-2) : 127 - 136
  • [5] Effects of zotepine on extracellular levels of monoamine, GABA and glutamate in rat prefrontal cortex
    Yamamura, S.
    Ohoyama, K.
    Hamaguchi, T.
    Nakagawa, M.
    Suzuki, D.
    Matsumoto, T.
    Motomura, E.
    Tanii, H.
    Shiroyama, T.
    Okada, M.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2009, 157 (04) : 656 - 665
  • [6] Effect of zotepine on extracellular monoamine levels in rat prefrontal cortex
    Nakamura, S
    Ago, Y
    Harasawa, T
    Koyama, Y
    Baba, A
    Matsuda, T
    [J]. JOURNAL OF PHARMACOLOGICAL SCIENCES, 2005, 97 : 152P - 152P
  • [7] Brain region and dose effects of an olanzapine/fluoxetine combination on extracellular monoamine concentrations in the rat
    Koch, S
    Perry, KW
    Bymaster, FP
    [J]. NEUROPHARMACOLOGY, 2004, 46 (02) : 232 - 242
  • [8] Effects of antipsychotic drugs on extracellular dopamine levels in rat medial prefrontal cortex and nucleus accumbens
    Kuroki, T
    Meltzer, HY
    Ichikawa, J
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1999, 288 (02): : 774 - 781
  • [9] Effects of acute and chronic administration of venlafaxine and desipramine on extracellular monoamine levels in the mouse prefrontal cortex and striatum
    Higashino, Kosuke
    Ago, Yukio
    Umehara, Masato
    Kita, Yuki
    Fujita, Kazumi
    Takuma, Kazuhiro
    Matsuda, Toshio
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2014, 729 : 86 - 93
  • [10] Clozapine and olanzapine, but not haloperidol or risperidon, attenuate high K+-evoked extracellular glutamate levels in rat medial prefrontal cortex
    Kajihata, T
    Kuroki, K
    Motomura, K
    Hondo, H
    Nakahara, T
    Tashiro, N
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2002, 17 : S123 - S123